Generics Global Industry Almanac 2017-2021

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

– For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

The market value is evaluated at ex-factory prices.

Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.

Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.

Please note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.

All currency conversions were calculated at constant average annual 2016 exchange rates.

– The global generics market had total revenues of $311.1bn in 2016, representing a compound annual growth rate (CAGR) of 9.5% between 2012 and 2016.

– Market consumption volume increased with a CAGR of 2.2% between 2012 and 2016, to reach a total of 82.1% of total pharma volume in 2016.

– Strong growth will continue in the emerging markets but worldwide there will be a deceleration.

Scope

– Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market

– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market

– Leading company profiles reveal details of key generics market players’ global operations and financial performance

– Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume

Reasons to buy

- What was the size of the global generics market by value in 2016?

- What will be the size of the global generics market in 2021?

- What factors are affecting the strength of competition in the global generics market?

- How has the market performed over the last five years?

- How large is the global generics market in relation to its regional counterparts?

Table of Contents

Table of Contents

EXECUTIVE SUMMARY 2

Market value 2

Market value forecast 2

Market volume 2

Market volume forecast 2

Geography segmentation 2

Introduction 32

What is this report about? 32

Who is the target reader? 32

How to use this report 32

Definitions 32

Global Generics 33

Market Overview 33

Market Data 34

Market Segmentation 36

Market outlook 37

Five forces analysis 39

Generics in Asia-Pacific 45

Market Overview 45

Market Data 46

Market Segmentation 48

Market outlook 49

Five forces analysis 51

Generics in Europe 57

Market Overview 57

Market Data 58

Market Segmentation 60

Market outlook 61

Five forces analysis 63

Generics in France 69

Market Overview 69

Market Data 70

Market Segmentation 72

Market outlook 73

Five forces analysis 75

Macroeconomic indicators 81

Generics in Germany 83

Market Overview 83

Market Data 84

Market Segmentation 86

Market outlook 87

Five forces analysis 89

Macroeconomic indicators 95

Generics in Australia 97

Market Overview 97

Market Data 98

Market Segmentation 100

Market outlook 101

Five forces analysis 103

Macroeconomic indicators 109

Generics in Brazil 111

Market Overview 111

Market Data 112

Market Segmentation 114

Market outlook 115

Five forces analysis 117

Macroeconomic indicators 123

Generics in Canada 125

Market Overview 125

Market Data 126

Market Segmentation 128

Market outlook 129

Five forces analysis 131

Macroeconomic indicators 137

Generics in China 139

Market Overview 139

Market Data 140

Market Segmentation 142

Market outlook 143

Five forces analysis 145

Macroeconomic indicators 152

Generics in India 154

Market Overview 154

Market Data 155

Market Segmentation 157

Market outlook 158

Five forces analysis 160

Macroeconomic indicators 166

Generics in Indonesia 168

Market Overview 168

Market Data 169

Market Segmentation 171

Market outlook 172

Five forces analysis 174

Macroeconomic indicators 180

Generics in Italy 182

Market Overview 182

Market Data 183

Market Segmentation 185

Market outlook 186

Five forces analysis 188

Macroeconomic indicators 194

Generics in Japan 196

Market Overview 196

Market Data 197

Market Segmentation 199

Market outlook 200

Five forces analysis 202

Macroeconomic indicators 208

Generics in Mexico 210

Market Overview 210

Market Data 211

Market Segmentation 213

Market outlook 214

Five forces analysis 216

Macroeconomic indicators 222

Generics in The Netherlands 224

Market Overview 224

Market Data 225

Market Segmentation 227

Market outlook 228

Five forces analysis 230

Macroeconomic indicators 236

Generics in North America 238

Market Overview 238

Market Data 239

Market Segmentation 241

Market outlook 242

Five forces analysis 244

Generics in Russia 251

Market Overview 251

Market Data 252

Market Segmentation 254

Market outlook 255

Five forces analysis 257

Macroeconomic indicators 263

Generics in Scandinavia 265

Market Overview 265

Market Data 266

Market Segmentation 268

Market outlook 269

Five forces analysis 271

Generics in Singapore 277

Market Overview 277

Market Data 278

Market Segmentation 280

Market outlook 281

Five forces analysis 283

Macroeconomic indicators 289

Generics in South Africa 291

Market Overview 291

Market Data 292

Market Segmentation 294

Market outlook 295

Five forces analysis 297

Macroeconomic indicators 303

Generics in South Korea 305

Market Overview 305

Market Data 306

Market Segmentation 308

Market outlook 309

Five forces analysis 311

Macroeconomic indicators 317

Generics in Spain 319

Market Overview 319

Market Data 320

Market Segmentation 322

Market outlook 323

Five forces analysis 325

Macroeconomic indicators 331

Generics in Turkey 333

Market Overview 333

Market Data 334

Market Segmentation 336

Market outlook 337

Five forces analysis 339

Macroeconomic indicators 345

Generics in The United Kingdom 347

Market Overview 347

Market Data 348

Market Segmentation 350

Market outlook 351

Five forces analysis 353

Macroeconomic indicators 359

Generics in The United States 361

Market Overview 361

Market Data 362

Market Segmentation 364

Market outlook 365

Five forces analysis 367

Macroeconomic indicators 373

Company Profiles 375

Leading Companies 375

Appendix 447

Methodology 447

About MarketLine 448

List of Tables

List of Tables

Table 1: Global generics market value: $ billion, 2012-16

Table 2: Global generics market volume: % of total pharma volume, 2012-16

Table 3: Global generics market geography segmentation: $ billion, 2016

Table 4: Global generics market value forecast: $ billion, 2016-21

Table 5: Global generics market volume forecast: % of total pharma volume, 2016-21

Table 6: Asia-Pacific generics market value: $ billion, 2012-16

Table 7: Asia-Pacific generics market volume: % of total pharma volume, 2012-16

Table 8: Asia-Pacific generics market geography segmentation: $ billion, 2016

Table 9: Asia-Pacific generics market value forecast: $ billion, 2016-21

Table 10: Asia-Pacific generics market volume forecast: % of total pharma volume, 2016-21

Table 11: Europe generics market value: $ billion, 2012-16

Table 12: Europe generics market volume: % of total pharma volume, 2012-16

Table 13: Europe generics market geography segmentation: $ billion, 2016

Table 14: Europe generics market value forecast: $ billion, 2016-21

Table 15: Europe generics market volume forecast: % of total pharma volume, 2016-21

Table 16: France generics market value: $ million, 2012-16

Table 17: France generics market volume: % of total pharma volume, 2012-16

Table 18: France generics market geography segmentation: $ million, 2016

Table 19: France generics market value forecast: $ million, 2016-21

Table 20: France generics market volume forecast: % of total pharma volume, 2016-21

Table 21: France size of population (million), 2012-16

Table 22: France gdp (constant 2005 prices, $ billion), 2012-16

Table 23: France gdp (current prices, $ billion), 2012-16

Table 24: France inflation, 2012-16

Table 25: France consumer price index (absolute), 2012-16

Table 26: France exchange rate, 2012-16

Table 27: Germany generics market value: $ million, 2012-16

Table 28: Germany generics market volume: % of total pharma volume, 2012-16

Table 29: Germany generics market geography segmentation: $ million, 2016

Table 30: Germany generics market value forecast: $ million, 2016-21

Table 31: Germany generics market volume forecast: % of total pharma volume, 2016-21

Table 32: Germany size of population (million), 2012-16

Table 33: Germany gdp (constant 2005 prices, $ billion), 2012-16

Table 34: Germany gdp (current prices, $ billion), 2012-16

Table 35: Germany inflation, 2012-16

Table 36: Germany consumer price index (absolute), 2012-16

Table 37: Germany exchange rate, 2012-16

Table 38: Australia generics market value: $ million, 2012-16

Table 39: Australia generics market volume: % of total pharma volume, 2012-16

Table 40: Australia generics market geography segmentation: $ million, 2016

Table 41: Australia generics market value forecast: $ million, 2016-21

Table 42: Australia generics market volume forecast: % of total pharma volume, 2016-21

Table 43: Australia size of population (million), 2012-16

Table 44: Australia gdp (constant 2005 prices, $ billion), 2012-16

Table 45: Australia gdp (current prices, $ billion), 2012-16

Table 46: Australia inflation, 2012-16

Table 47: Australia consumer price index (absolute), 2012-16

Table 48: Australia exchange rate, 2012-16

Table 49: Brazil generics market value: $ million, 2012-16

Table 50: Brazil generics market volume: % of total pharma volume, 2012-16

Table 51: Brazil generics market geography segmentation: $ million, 2016

Table 52: Brazil generics market value forecast: $ million, 2016-21

Table 53: Brazil generics market volume forecast: % of total pharma volume, 2016-21

Table 54: Brazil size of population (million), 2012-16

Table 55: Brazil gdp (constant 2005 prices, $ billion), 2012-16

Table 56: Brazil gdp (current prices, $ billion), 2012-16

Table 57: Brazil inflation, 2012-16

Table 58: Brazil consumer price index (absolute), 2012-16

Table 59: Brazil exchange rate, 2012-16

Table 60: Canada generics market value: $ million, 2012-16

Table 61: Canada generics market volume: % of total pharma volume, 2012-16

Table 62: Canada generics market geography segmentation: $ million, 2016

Table 63: Canada generics market value forecast: $ million, 2016-21

Table 64: Canada generics market volume forecast: % of total pharma volume, 2016-21

Table 65: Canada size of population (million), 2012-16

Table 66: Canada gdp (constant 2005 prices, $ billion), 2012-16

Table 67: Canada gdp (current prices, $ billion), 2012-16

Table 68: Canada inflation, 2012-16

Table 69: Canada consumer price index (absolute), 2012-16

Table 70: Canada exchange rate, 2012-16

Table 71: China generics market value: $ billion, 2012-16

Table 72: China generics market volume: % of total pharma volume, 2012-16

Table 73: China generics market geography segmentation: $ billion, 2016

Table 74: China generics market value forecast: $ billion, 2016-21

Table 75: China generics market volume forecast: % of total pharma volume, 2016-21

List of Figures

List of Figures

Figure 1: Global generics market value: $ billion, 2012-16

Figure 2: Global generics market volume: % of total pharma volume, 2012-16

Figure 3: Global generics market geography segmentation: % share, by value, 2016

Figure 4: Global generics market value forecast: $ billion, 2016-21

Figure 5: Global generics market volume forecast: % of total pharma volume, 2016-21

Figure 6: Forces driving competition in the global generics market, 2016

Figure 7: Drivers of buyer power in the global generics market, 2016

Figure 8: Drivers of supplier power in the global generics market, 2016

Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2016

Figure 10: Factors influencing the threat of substitutes in the global generics market, 2016

Figure 11: Drivers of degree of rivalry in the global generics market, 2016

Figure 12: Asia-Pacific generics market value: $ billion, 2012-16

Figure 13: Asia-Pacific generics market volume: % of total pharma volume, 2012-16

Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2016

Figure 15: Asia-Pacific generics market value forecast: $ billion, 2016-21

Figure 16: Asia-Pacific generics market volume forecast: % of total pharma volume, 2016-21

Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2016

Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2016

Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2016

Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2016

Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2016

Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2016

Figure 23: Europe generics market value: $ billion, 2012-16

Figure 24: Europe generics market volume: % of total pharma volume, 2012-16

Figure 25: Europe generics market geography segmentation: % share, by value, 2016

Figure 26: Europe generics market value forecast: $ billion, 2016-21

Figure 27: Europe generics market volume forecast: % of total pharma volume, 2016-21

Figure 28: Forces driving competition in the generics market in Europe, 2016

Figure 29: Drivers of buyer power in the generics market in Europe, 2016

Figure 30: Drivers of supplier power in the generics market in Europe, 2016

Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2016

Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2016

Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2016

Figure 34: France generics market value: $ million, 2012-16

Figure 35: France generics market volume: % of total pharma volume, 2012-16

Figure 36: France generics market geography segmentation: % share, by value, 2016

Figure 37: France generics market value forecast: $ million, 2016-21

Figure 38: France generics market volume forecast: % of total pharma volume, 2016-21

Figure 39: Forces driving competition in the generics market in France, 2016

Figure 40: Drivers of buyer power in the generics market in France, 2016

Figure 41: Drivers of supplier power in the generics market in France, 2016

Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2016

Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2016

Figure 44: Drivers of degree of rivalry in the generics market in France, 2016

Figure 45: Germany generics market value: $ million, 2012-16

Figure 46: Germany generics market volume: % of total pharma volume, 2012-16

Figure 47: Germany generics market geography segmentation: % share, by value, 2016

Figure 48: Germany generics market value forecast: $ million, 2016-21

Figure 49: Germany generics market volume forecast: % of total pharma volume, 2016-21

Figure 50: Forces driving competition in the generics market in Germany, 2016

Figure 51: Drivers of buyer power in the generics market in Germany, 2016

Figure 52: Drivers of supplier power in the generics market in Germany, 2016

Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2016

Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2016

Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2016

Figure 56: Australia generics market value: $ million, 2012-16

Figure 57: Australia generics market volume: % of total pharma volume, 2012-16

Figure 58: Australia generics market geography segmentation: % share, by value, 2016

Figure 59: Australia generics market value forecast: $ million, 2016-21

Figure 60: Australia generics market volume forecast: % of total pharma volume, 2016-21

Figure 61: Forces driving competition in the generics market in Australia, 2016

Figure 62: Drivers of buyer power in the generics market in Australia, 2016

Figure 63: Drivers of supplier power in the generics market in Australia, 2016

Figure 64: Factors influencing the likelihood of new entrants in the generics market in Australia, 2016

Figure 65: Factors influencing the threat of substitutes in the generics market in Australia, 2016

Figure 66: Drivers of degree of rivalry in the generics market in Australia, 2016

Figure 67: Brazil generics market value: $ million, 2012-16

Figure 68: Brazil generics market volume: % of total pharma volume, 2012-16

Figure 69: Brazil generics market geography segmentation: % share, by value, 2016

Figure 70: Brazil generics market value forecast: $ million, 2016-21

Figure 71: Brazil generics market volume forecast: % of total pharma volume, 2016-21

Figure 72: Forces driving competition in the generics market in Brazil, 2016

Figure 73: Drivers of buyer power in the generics market in Brazil, 2016

Figure 74: Drivers of supplier power in the generics market in Brazil, 2016

Figure 75: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2016

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports